Latest Blog Posts Tagged "Research News"
August 14, 2015
Neuropore Therapies and Biogen grow the field of clinical trials with approaches against alpha-synuclein, our most promising target for a therapy to slow or stop Parkinson's progression.
July 29, 2015
Drugs in development that go after the processes, rather than the proteins, involved in Alzheimer's onset may have potential to treat Parkinson's disease, as well.
July 27, 2015
Tanya Simuni, MD, spoke to us about results from a trial of diabetes drug pioglitazone for PD treatment and what her team's findings mean for this vein of Parkinson's research.
June 26, 2015
MJFF staff share news from the 19th International Congress of Parkinson's Disease and Movement Disorders last week in San Diego.
June 25, 2015
Todd Sherer, PhD, shares updates on MJFF progress in 2015.
June 16, 2015
The U.S. Food and Drug Administration announced Friday that it had approved another deep brain stimulation device for treatment of Parkinson's disease and essential tremor.
May 29, 2015
Earlier this year MJFF launched two programs investigating the unknowns around alpha-synuclein, our most promising target for a disease-modifying therapy.
May 18, 2015
MJFF, with The Edmond J. Safra Foundation, has selected four centers in the United States and one in Canada to host the inaugural class of the Edmond J. Safra Fellowship in Movement Disorders.
May 11, 2015
Dr. Laurie Mischley discusses some of the challenges that research into complementary and alternative approaches to managing Parkinson's face.
May 06, 2015
Dr. Rachel Dolhun tells Practical Neurology about recently approved levodopa formulations that may help avoid wearing off and dyskinesia.